Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LDR’s Mobi-C Two-Level Cervical Disc On Track For 2013 Launch Following “Approvable” Letter

This article was originally published in The Gray Sheet

Executive Summary

Final PMA approval for the artificial cervical disc implant remains subject to FDA review of labeling and quality system requirements.

You may also be interested in...



Cervical Disc Replacement Data Looks Good, But More Needed

Long-term positive outcomes for artificial cervical discs were reported, but the market remains muted by insurance restrictions, and even more data may be needed for a breakthrough.

News In Brief

Utah Medical buys Femcare

LDR Spine Submits PMA For Mobi-C Artificial Cervical Disc

LDR Spine expects to gain FDA approval by early 2012 for its Mobi-C artificial cervical disc for single-level implantation after submitting a PMA Jan. 14.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031729

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel